ONTOLOGY REPORT - ANNOTATIONS
| Term: | dimethylarsinic acid |
|
| Accession: | CHEBI:48765
|
browse the term
|
| Definition: | The organoarsenic compound that is arsenic acid substituted on the central arsenic atom with two methyl groups. |
| Synonyms: | related_synonym: | C2H7AsO2; CACODYLIC ACID; C[As](C)(O)=O; InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5); InChIKey=OGGXGZAMXPVRFZ-UHFFFAOYSA-N; Kakodylsaeure; Me2As(=O)OH; [As(CH3)2O(OH)] |
| | alt_id: | CHEBI:29839; CHEBI:48764 |
| | xref_casrn: | 75-60-5 |
| | xref: | ChEMBL:793994 "ChEMBL COMPOUND"; ChemIDplus:1736965 "Beilstein Registry Number"; ChemIDplus:75-60-5 "CAS Registry Number"; CiteXplore:11379771 "PubMed citation"; CiteXplore:21342701 "PubMed citation"; CiteXplore:21457993 "PubMed citation"; CiteXplore:21608259 "PubMed citation"; Gmelin:130562 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D002101 |
| | xref: | NIST Chemistry WebBook:75-60-5 "CAS Registry Number"; PDBeChem:CAD "PDBeChem"; Wikipedia:Cacodylic_acid "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:16223 |
|
|
dimethylarsinic acid
|
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
increases expression |
EXP |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agtrap |
angiotensin II receptor-associated protein |
|
decreases expression |
ISO |
5 |
165,154,252 |
165,164,570 |
RGD:6480464 |
CTD |
| G |
Aoc3 |
amine oxidase, copper containing 3 |
|
increases expression |
ISO |
10 |
90,357,094 |
90,365,040 |
RGD:6480464 |
CTD |
| G |
Aoc3 |
amine oxidase, copper containing 3 |
|
multiple interactions |
ISO |
10 |
90,357,094 |
90,365,040 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp7 |
aquaporin 7 |
|
increases expression |
EXP |
5 |
58,433,731 |
58,447,853 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arhgap21 |
Rho GTPase activating protein 21 |
|
increases expression |
ISO |
17 |
94,817,558 |
94,941,088 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
multiple interactions |
ISO |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
decreases expression |
EXP |
1 |
187,189,665 |
187,194,336 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
decreases expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type IA |
|
increases expression |
EXP |
16 |
10,061,943 |
10,105,854 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
increases expression |
EXP |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
increases expression |
EXP |
6 |
64,161,641 |
64,162,751 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
increases expression |
EXP |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
|
increases expression |
EXP |
5 |
142,174,441 |
142,201,120 |
RGD:6480464 |
CTD |
| G |
Capn9 |
calpain 9 |
|
increases expression |
EXP |
19 |
54,759,009 |
54,796,390 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
increases expression |
ISO |
8 |
71,017,732 |
71,070,729 |
RGD:6480464 |
CTD |
| G |
Car13 |
carbonic anhydrase 13 |
|
increases expression |
ISO |
2 |
88,271,908 |
88,309,336 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
ISO |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases response to substance |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases response to substance |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases response to substance |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav2 |
caveolin 2 |
|
decreases expression |
ISO |
4 |
42,932,127 |
42,939,503 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
affects expression |
EXP |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Cd2 |
Cd2 molecule |
|
increases expression |
EXP |
2 |
196,332,547 |
196,346,221 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cdc123 |
cell division cycle 123 |
|
increases expression |
EXP |
17 |
83,520,539 |
83,562,898 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
increases expression |
EXP |
8 |
20,164,150 |
20,176,763 |
RGD:6480464 |
CTD |
| G |
Cdc5l |
cell division cycle 5-like |
|
increases expression |
EXP |
9 |
11,165,631 |
11,204,135 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh4l |
cadherin 4-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdh4l |
cadherin 4-like |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
decreases expression |
EXP |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
increases expression |
EXP |
3 |
11,672,861 |
11,677,709 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
decreases expression |
EXP |
1 |
87,552,695 |
87,559,447 |
RGD:6480464 |
CTD |
| G |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
|
decreases expression |
EXP |
8 |
113,882,883 |
113,923,950 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases activity |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chek2 |
checkpoint kinase 2 |
|
increases expression |
EXP |
12 |
45,933,900 |
45,965,427 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
decreases expression |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Comp |
cartilage oligomeric matrix protein |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
decreases expression |
EXP |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Ctnnd2 |
catenin (cadherin-associated protein), delta 2 |
|
increases expression |
ISO |
2 |
82,238,091 |
83,088,901 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
multiple interactions |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
increases expression |
ISO |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
increases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
increases expression |
ISO |
X |
21,498,202 |
21,505,416 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
decreases expression |
EXP |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif2s3y |
eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked |
|
increases expression |
ISO |
2 |
102,222,332 |
102,223,486 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
increases expression |
EXP |
2 |
49,098,743 |
49,155,221 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
increases expression |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
decreases expression |
ISO |
4 |
163,468,604 |
163,476,325 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fibcd1 |
fibrinogen C domain containing 1 |
|
decreases expression |
ISO |
3 |
10,916,777 |
10,950,489 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
decreases expression |
EXP |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
increases expression |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
EXP |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Fut11 |
fucosyltransferase 11 (alpha (1,3) fucosyltransferase) |
|
decreases expression |
ISO |
15 |
3,824,218 |
3,827,778 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gak |
cyclin G associated kinase |
|
increases expression |
EXP |
14 |
1,630,890 |
1,710,373 |
RGD:6480464 |
CTD |
| G |
Gdi2 |
GDP dissociation inhibitor 2 |
|
increases expression |
EXP |
17 |
77,843,481 |
77,870,171 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
increases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
increases expression |
EXP |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
increases expression |
ISO |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Gng5 |
guanine nucleotide binding protein (G protein), gamma 5 |
|
increases expression |
ISO |
2 |
244,702,876 |
244,711,373 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
increases expression |
EXP |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
increases expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
decreases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
|
increases expression |
EXP |
15 |
56,803,445 |
56,925,046 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
increases expression |
EXP |
7 |
117,001,334 |
117,003,194 |
RGD:6480464 |
CTD |
| G |
Hapln2 |
hyaluronan and proteoglycan link protein 2 |
|
decreases expression |
EXP |
2 |
180,104,684 |
180,110,113 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
decreases expression |
EXP |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeo box A2 |
|
decreases expression |
EXP |
4 |
80,462,651 |
80,464,927 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
decreases expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4-like |
|
multiple interactions |
ISO |
2 |
127,697,504 |
127,751,085 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4-like |
|
decreases expression |
ISO |
2 |
127,697,504 |
127,751,085 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
decreases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
multiple interactions |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
decreases expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
multiple interactions |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
ISO |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
EXP |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
decreases expression |
ISO |
4 |
56,407,560 |
56,418,694 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
decreases expression |
EXP |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
|
increases expression |
EXP |
16 |
6,341,043 |
6,358,767 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
decreases expression |
EXP |
3 |
125,181,063 |
125,216,481 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases expression |
EXP |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
increases expression |
EXP |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
increases expression |
ISO |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
multiple interactions |
ISO |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt25 |
keratin 25 |
|
increases expression |
ISO |
10 |
88,217,581 |
88,224,858 |
RGD:6480464 |
CTD |
| G |
Krtap14 |
keratin associated protein 14 |
|
increases expression |
ISO |
11 |
28,648,990 |
28,649,832 |
RGD:6480464 |
CTD |
| G |
Krtap8-1 |
keratin associated protein 8-1 |
|
increases expression |
ISO |
11 |
29,276,201 |
29,276,386 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lman1 |
lectin, mannose-binding, 1 |
|
increases expression |
EXP |
18 |
62,504,296 |
62,524,151 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
decreases expression |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
|
increases expression |
ISO |
10 |
92,406,098 |
92,456,276 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
|
decreases expression |
ISO |
5 |
151,873,619 |
151,885,483 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
|
decreases expression |
ISO |
1 |
84,094,589 |
84,116,015 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mas1 |
MAS1 oncogene |
|
decreases expression |
ISO |
1 |
42,154,786 |
42,185,750 |
RGD:6480464 |
CTD |
| G |
Mbtps1 |
membrane-bound transcription factor peptidase, site 1 |
|
increases expression |
EXP |
19 |
49,751,424 |
49,802,700 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
increases expression |
EXP |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
increases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp17 |
matrix metallopeptidase 17 |
|
increases expression |
ISO |
12 |
28,142,947 |
28,168,483 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
decreases expression |
EXP |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mta1 |
metastasis associated 1 |
|
increases expression |
EXP |
6 |
138,118,468 |
138,143,983 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma 1, DAN family BMP antagonist |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Neo1 |
neogenin 1 |
|
increases expression |
ISO |
8 |
62,681,481 |
62,789,841 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
increases expression |
EXP |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfic |
nuclear factor I/C |
|
increases expression |
EXP |
7 |
9,768,135 |
9,793,584 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
increases expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
increases expression |
EXP |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
affects expression |
EXP |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Notch3 |
notch 3 |
|
increases expression |
EXP |
7 |
12,688,267 |
12,740,015 |
RGD:6480464 |
CTD |
| G |
Npy5r |
neuropeptide Y receptor Y5 |
|
decreases expression |
ISO |
16 |
24,765,175 |
24,773,132 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Oaz1 |
ornithine decarboxylase antizyme 1 |
|
decreases expression |
ISO |
7 |
10,394,495 |
10,396,952 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
multiple interactions |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
increases expression |
EXP |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Olr1077 |
olfactory receptor 1077 |
|
decreases expression |
ISO |
7 |
12,100,017 |
12,100,946 |
RGD:6480464 |
CTD |
| G |
Olr1583 |
olfactory receptor 1583 |
|
decreases expression |
ISO |
13 |
89,424,463 |
89,425,404 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
increases expression |
EXP |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
decreases expression |
EXP |
11 |
70,529,961 |
70,588,511 |
RGD:6480464 |
CTD |
| G |
Pcdh1 |
protocadherin 1 |
|
decreases expression |
ISO |
18 |
31,110,955 |
31,124,786 |
RGD:6480464 |
CTD |
| G |
Pcdhb17 |
protocadherin beta 17 |
|
increases expression |
ISO |
18 |
30,296,770 |
30,299,187 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
increases expression |
EXP |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
decreases expression |
EXP |
1 |
172,409,282 |
172,577,108 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
decreases expression |
EXP |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
increases expression |
ISO |
9 |
13,057,988 |
13,100,289 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
increases expression |
EXP |
10 |
57,388,474 |
57,439,063 |
RGD:6480464 |
CTD |
| G |
Pola1 |
polymerase (DNA directed), alpha 1, catalytic subunit |
|
increases expression |
ISO |
X |
80,650,454 |
80,965,833 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pold4 |
polymerase (DNA-directed), delta 4, accessory subunit |
|
increases expression |
ISO |
1 |
206,815,462 |
206,817,131 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
increases expression |
ISO |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Polg |
polymerase (DNA directed), gamma |
|
increases expression |
ISO |
1 |
135,197,075 |
135,212,178 |
RGD:6480464 |
CTD |
| G |
Poli |
polymerase (DNA directed), iota |
|
increases expression |
ISO |
18 |
67,212,984 |
67,230,580 |
RGD:6480464 |
CTD |
| G |
Pou3f1 |
POU class 3 homeobox 1 |
|
decreases expression |
EXP |
5 |
143,981,547 |
143,984,527 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Preb |
prolactin regulatory element binding |
|
increases expression |
EXP |
6 |
25,401,759 |
25,405,561 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases expression |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcg |
protein kinase C, gamma |
|
increases expression |
EXP |
1 |
64,145,749 |
64,172,712 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
increases expression |
EXP |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
increases expression |
EXP |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Rab10 |
RAB10, member RAS oncogene family |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
increases expression |
EXP |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rab14 |
RAB14, member RAS oncogene family |
|
decreases expression |
EXP |
3 |
14,245,693 |
14,255,984 |
RGD:6480464 |
CTD |
| G |
Rab1a |
RAB1A, member RAS oncogene family |
|
increases expression |
EXP |
14 |
100,973,039 |
101,027,893 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
decreases expression |
ISO |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
increases expression |
EXP |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
increases expression |
EXP |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
increases expression |
EXP |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
EXP |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Reg3b |
regenerating islet-derived 3 beta |
|
decreases expression |
EXP |
4 |
112,355,773 |
112,359,011 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
decreases expression |
EXP |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
increases expression |
EXP |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Scn2a1 |
sodium channel, voltage-gated, type II, alpha 1 |
|
decreases expression |
EXP |
3 |
47,588,413 |
47,722,800 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shq1 |
SHQ1, H/ACA ribonucleoprotein assembly factor |
|
decreases expression |
ISO |
4 |
135,478,202 |
135,571,298 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
decreases expression |
ISO |
12 |
30,111,863 |
30,131,134 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
|
increases expression |
ISO |
5 |
124,107,948 |
124,154,018 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
increases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, extracellular matrix protein |
|
decreases expression |
EXP |
1 |
171,700,495 |
172,020,808 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
decreases expression |
EXP |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Traf3 |
Tnf receptor-associated factor 3 |
|
decreases expression |
ISO |
6 |
135,925,375 |
136,027,270 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
increases expression |
ISO |
3 |
59,404,023 |
59,665,308 |
RGD:6480464 |
CTD |
| G |
Ttn |
titin |
|
increases expression |
ISO |
3 |
59,404,023 |
59,665,308 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
increases expression |
EXP |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
increases expression |
EXP |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
increases expression |
EXP |
2 |
232,943,214 |
232,971,022 |
RGD:6480464 |
CTD |
| G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
|
decreases expression |
ISO |
20 |
11,367,545 |
11,389,283 |
RGD:6480464 |
CTD |
| G |
Usf2 |
upstream transcription factor 2, c-fos interacting |
|
increases expression |
EXP |
1 |
85,981,897 |
85,993,346 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
increases expression |
EXP |
8 |
47,052,085 |
47,076,321 |
RGD:6480464 |
CTD |
| G |
Usp7 |
ubiquitin specific peptidase 7 (herpes virus-associated) |
|
increases expression |
ISO |
10 |
6,917,612 |
6,963,452 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
decreases expression |
EXP |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
increases expression |
ISO |
16 |
40,624,435 |
40,739,692 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases expression |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
increases expression |
EXP |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
Term paths to the root
|